- Home
- SYRE vs HQH Comparison
SYRE vs HQH Comparison
Compare SYRE & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- HQH
- Stock Information
- Founded
- SYRE 2013
- HQH 1986
- Country
- SYRE United States
- HQH United States
- Employees
- SYRE N/A
- HQH N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- HQH Finance Companies
- Sector
- SYRE Health Care
- HQH Finance
- Exchange
- SYRE Nasdaq
- HQH Nasdaq
- Market Cap
- SYRE 897.9M
- HQH 788.2M
- IPO Year
- SYRE 2016
- HQH N/A
- Fundamental
- Price
- SYRE $12.67
- HQH $15.10
- Analyst Decision
- SYRE Buy
- HQH
- Analyst Count
- SYRE 8
- HQH 0
- Target Price
- SYRE $50.00
- HQH N/A
- AVG Volume (30 Days)
- SYRE 899.5K
- HQH 183.8K
- Earning Date
- SYRE 05-08-2025
- HQH 01-01-0001
- Dividend Yield
- SYRE N/A
- HQH 11.56%
- EPS Growth
- SYRE N/A
- HQH N/A
- EPS
- SYRE N/A
- HQH 1.09
- Revenue
- SYRE N/A
- HQH N/A
- Revenue This Year
- SYRE N/A
- HQH N/A
- Revenue Next Year
- SYRE N/A
- HQH N/A
- P/E Ratio
- SYRE N/A
- HQH $15.24
- Revenue Growth
- SYRE N/A
- HQH N/A
- 52 Week Low
- SYRE $10.91
- HQH $14.31
- 52 Week High
- SYRE $40.49
- HQH $17.94
- Technical
- Relative Strength Index (RSI)
- SYRE 36.18
- HQH 40.76
- Support Level
- SYRE $12.04
- HQH $14.98
- Resistance Level
- SYRE $13.29
- HQH $15.10
- Average True Range (ATR)
- SYRE 1.27
- HQH 0.55
- MACD
- SYRE 0.01
- HQH 0.04
- Stochastic Oscillator
- SYRE 26.02
- HQH 50.38
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.